Spine Registration Using 3D-Scanning
Launched by ADVANCED SCANNERS INC. · Feb 12, 2024
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients that require exposure of posterior bony anatomy for visualization as standard of care.
- • 2. Patients will have had a CT scan performed prior to the procedure as standard of care, or is expected to have a CT scan intraoperatively as standard of care.
- • 3. Clinically planned for spine surgery.
- • 4. Able to provide written informed consent from subject, using IRB approved consent form and agrees to comply with protocol requirements.
- • 5. Patients who do not speak English will be allowed to participate, with the expectation that the site will provide interpreter services to help with the consent process.
- Exclusion Criteria:
- • 1. Language problems that would prevent from properly understanding instructions in any language.
- • 2. Patients less than 18 years of age or older than 80 years of age
- • 3. Patients who are excluded from consideration for the surgical procedure are therefore excluded from the research study.
- • 4. Special populations: pregnant women, prisoners.
- • 5. Minimally invasive spine surgery that does not expose the necessary bone/s.
- • 6. Spine surgery without posterior exposure.
- • 7. Patients considered high risk for anesthesia, as determined by operative surgeon
About Advanced Scanners Inc.
Advanced Scanners Inc. is a leading clinical trial sponsor specializing in the development and implementation of innovative imaging technologies for medical research. Committed to advancing healthcare through scientific excellence, the company focuses on enhancing diagnostic accuracy and treatment efficacy across various therapeutic areas. With a robust portfolio of advanced scanning solutions, Advanced Scanners Inc. collaborates with healthcare institutions and research organizations to facilitate groundbreaking clinical trials that aim to improve patient outcomes and drive medical advancements. Their dedication to rigorous research standards and regulatory compliance ensures the reliability and integrity of data generated in all studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Aaron Bernstein, PhD
Study Director
Advanced Scanners Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported